{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:01:50Z","timestamp":1793502110687,"version":"4.5.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1093\/neuonc\/nor203","type":"journal-article","created":{"date-parts":[[2011,12,13]],"date-time":"2011-12-13T02:15:32Z","timestamp":1323742532000},"page":"368-380","source":"Crossref","is-referenced-by-count":131,"title":["Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL)"],"prefix":"10.1093","volume":"14","author":[{"given":"Takashi","family":"Sasayama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Nakamizo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamitsu","family":"Nishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsufumi","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotomo","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsu","family":"Mizukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohkichi","family":"Hosoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Kohmura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,12,12]]},"reference":[{"key":"key\n\t\t\t\t20170508182748_NOR203C1","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/cncr.10851","article-title":"The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis","volume":"95","author":"Olson","year":"2002","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20170508182748_NOR203C2","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1634\/theoncologist.2008-0236","article-title":"Primary CNS lymphoma in immunocompetent patients","volume":"14","author":"Sierra del Rio","year":"2009","journal-title":"Oncologist"},{"key":"key\n\t\t\t\t20170508182748_NOR203C3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3171\/jns.2000.92.2.0261","article-title":"Primary intracerebral malignant lymphoma: report of 248 cases","volume":"92","author":"Bataille","year":"2000","journal-title":"J Neurosurg"},{"key":"key\n\t\t\t\t20170508182748_NOR203C4","volume-title":"Neuro-Oncology: The Essentials","author":"Bernstein","year":"2000"},{"key":"key\n\t\t\t\t20170508182748_NOR203C5","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1200\/JCO.1999.17.2.554","article-title":"Value of combined approach with thallium-201 single-photon emission computed tomography and Epstein-Barr virus DNA polymerase chain reaction in CSF for the diagnosis of AIDS-related primary CNS lymphoma","volume":"17","author":"Antinori","year":"1999","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20170508182748_NOR203C6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1470-2045(05)70513-1","article-title":"Inherited cytokine response and risk of lymphoma","volume":"7","author":"Salles","year":"2006","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t20170508182748_NOR203C7","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1002\/1097-0142(20010915)92:6+<1684::AID-CNCR1497>3.0.CO;2-Z","article-title":"The role of cytokines in cancer-related fatigue","volume":"92","author":"Kurzrock","year":"2001","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20170508182748_NOR203C8","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1182\/blood.V74.2.798.798","article-title":"A possible autocrine role for interleukin-6 in two lymphoma cell lines","volume":"74","author":"Yee","year":"1989","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170508182748_NOR203C9","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1189\/jlb.0705358","article-title":"Interleukin-10 and the immune response against cancer: a counterpoint","volume":"78","author":"Mocellin","year":"2005","journal-title":"J Leukoc Biol"},{"key":"key\n\t\t\t\t20170508182748_NOR203C10","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"key\n\t\t\t\t20170508182748_NOR203C11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-065X.2008.00706.x","article-title":"Interleukin-10: new perspectives on an old cytokine","volume":"226","author":"Mosser","year":"2008","journal-title":"Immunol Rev"},{"key":"key\n\t\t\t\t20170508182748_NOR203C12","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-065X.2008.00635.x","article-title":"Strategies for use of IL-10 or its antagonists in human disease","volume":"223","author":"O'Garra","year":"2008","journal-title":"Immunol Rev"},{"key":"key\n\t\t\t\t20170508182748_NOR203C13","first-page":"709","article-title":"Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis","volume":"7","author":"Alas","year":"2001","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t20170508182748_NOR203C14","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1038\/sj.onc.1207336","article-title":"Rituximab inhibits p38 MAPK activity in 2F7 B NHL and decreases IL-10 transcription: pivotal role of p38 MAPK in drug resistance","volume":"23","author":"Vega","year":"2004","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170508182748_NOR203C15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF03167070","article-title":"Serum IL-10 and IL-6 levels at diagnosis as independent predictors of outcome in non-Hodgkin's lymphoma","volume":"60","author":"el-Far","year":"2004","journal-title":"J Physiol Biochem"},{"key":"key\n\t\t\t\t20170508182748_NOR203C16","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1751-553X.2007.00951.x","article-title":"Correlation of serum IL-6, IL-8 and IL-10 levels with clinicopathological features and prognosis in patients with diffuse large B-cell lymphoma","volume":"30","author":"Nacinovi\u0107-Duleti\u0107","year":"2008","journal-title":"Int J Lab Hematol"},{"key":"key\n\t\t\t\t20170508182748_NOR203C17","first-page":"274","article-title":"Serum interleukin-10 levels are an independent prognostic factor for patients with Hodgkin's lymphoma","volume":"86","author":"Vassilakopoulos","year":"2001","journal-title":"Haematologica"},{"key":"key\n\t\t\t\t20170508182748_NOR203C18","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1167\/iovs.06-0031","article-title":"IL-10 measurement in aqueous humor for screening patients with suspicion of primary intraocular lymphoma","volume":"48","author":"Cassoux","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key\n\t\t\t\t20170508182748_NOR203C19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00055735-200212000-00012","article-title":"Intraocular lymphoma","volume":"13","author":"Chan","year":"2002","journal-title":"Curr Opin Ophthalmol"},{"key":"key\n\t\t\t\t20170508182748_NOR203C20","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0161-6420(00)00401-2","article-title":"Interleukin-10 and intraocular-central nervous system lymphoma","volume":"108","author":"Cassoux","year":"2001","journal-title":"Ophthalmology"},{"key":"key\n\t\t\t\t20170508182748_NOR203C21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/1531-8249(200001)47:1<137::AID-ANA27>3.0.CO;2-K","article-title":"Cerebrospinal fluid interleukin-10 levels in primary central nervous system lymphoma: a possible marker of response to treatment?","volume":"47","author":"Salmaggi","year":"2000","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170508182748_NOR203C22","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/archopht.1997.01100160327010","article-title":"Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma","volume":"115","author":"Whitcup","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"key\n\t\t\t\t20170508182748_NOR203C23","first-page":"5137","article-title":"Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine\/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cytotoxic drugs","volume":"61","author":"Alas","year":"2001","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170508182748_NOR203C24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3109\/00313029009061421","article-title":"Cerebrospinal fluid \u03b22-microglobulin levels in meningeal involvement by malignancy","volume":"22","author":"Jeffery","year":"1990","journal-title":"Pathology"},{"key":"key\n\t\t\t\t20170508182748_NOR203C25","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1182\/blood.V87.5.1985.1985","article-title":"Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies","volume":"87","author":"Kersten","year":"1996","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170508182748_NOR203C26","first-page":"132","article-title":"Soluble interleukin-2 receptor levels in cerebrospinal fluid of patients with acute lymphocytic leukemia or with non-Hodgkin's lymphoma","volume":"22","author":"Chang","year":"1989","journal-title":"Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi"},{"key":"key\n\t\t\t\t20170508182748_NOR203C27","first-page":"407","article-title":"Significance of cerebrospinal fluid sIL-2R level as a marker of CNS involvement in acute lymphoblastic leukemia","volume":"35","author":"Lee","year":"2005","journal-title":"Ann Clin Lab Sci"},{"key":"key\n\t\t\t\t20170508182748_NOR203C28","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1200\/JCO.2007.12.1053","article-title":"Protein biomarker identification in the CSF of patients with CNS lymphoma","volume":"26","author":"Roy","year":"2008","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20170508182748_NOR203C29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0022-510X(94)90093-0","article-title":"Intrathecal synthesis of interleukin-10 (IL-10) in viral and inflammatory diseases of the central nervous system","volume":"126","author":"Gallo","year":"1994","journal-title":"J Neurol Sci"},{"key":"key\n\t\t\t\t20170508182748_NOR203C30","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1365-2141.1995.tb05205.x","article-title":"Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma","volume":"90","author":"De Luca","year":"1995","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t20170508182748_NOR203C31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jns.2007.09.023","article-title":"Cerebrospinal fluid cytokine responses in human eosinophilic meningitis associated with angiostrongyliasis","volume":"267","author":"Intapan","year":"2008","journal-title":"J Neurol Sci"},{"key":"key\n\t\t\t\t20170508182748_NOR203C32","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jneuroim.2003.08.040","article-title":"Cytokines and chemokines in neuro-Beh\u00e7et's disease compared to multiple sclerosis and other neurological diseases","volume":"145","author":"Saruhan-Direskeneli","year":"2003","journal-title":"J Neuroimmunol"},{"key":"key\n\t\t\t\t20170508182748_NOR203C33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000292023","article-title":"Changes in cerebrospinal fluid cytokine expression in tuberculous meningitis patients with treatment","volume":"17","author":"Kashyap","year":"2010","journal-title":"Neuroimmunomodulation"},{"key":"key\n\t\t\t\t20170508182748_NOR203C34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10072-006-0562-6","article-title":"Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimer's disease patients","volume":"27","author":"Rota","year":"2006","journal-title":"Neurol Sci"},{"key":"key\n\t\t\t\t20170508182748_NOR203C35","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1468-2982.2008.01727.x","article-title":"Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache","volume":"29","author":"B\u00f8","year":"2009","journal-title":"Cephalalgia"},{"key":"key\n\t\t\t\t20170508182748_NOR203C36","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1179\/016164107X235149","article-title":"Decreased levels of interleukin-10 and transforming growth factor-beta 2 in cerebrospinal fluid of patients with high grade astrocytoma","volume":"30","author":"Krzyszkowski","year":"2008","journal-title":"Neurol Res"},{"key":"key\n\t\t\t\t20170508182748_NOR203C37","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2141.2007.06570.x","article-title":"Interleukin-10 gene polymorphism influences the prognosis of T-cell non-Hodgkin lymphomas","volume":"137","author":"Lee","year":"2007","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t20170508182748_NOR203C38","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/(SICI)1099-1069(199909)17:3<117::AID-HON640>3.0.CO;2-1","article-title":"Preferential type 1-1 cytokine gene expressions in peripheral T-cell lymphomas","volume":"17","author":"Ho","year":"1999","journal-title":"Hematol Oncol"},{"key":"key\n\t\t\t\t20170508182748_NOR203C39","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/1097-0215(20010601)92:5<692::AID-IJC1237>3.0.CO;2-Z","article-title":"Expression of HLA class I, beta(2)-microglobulin, TAP1 and IL-10 in Epstein-Barr virus-associated nasal NK\/T-cell lymphoma: implications for tumor immune escape mechanism","volume":"92","author":"Shen","year":"2001","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t20170508182748_NOR203C40","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1002\/ijc.21688","article-title":"Clinical significance of serum Th1-, Th2- and regulatory T cells-associated cytokines in adult T-cell leukemia\/lymphoma: high interleukin-5 and -10 levels are significant unfavorable prognostic factors","volume":"118","author":"Inagaki","year":"2006","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t20170508182748_NOR203C41","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ajo.2009.04.005","article-title":"Primary T-cell lymphoma of the retina and cerebellum: immunophenotypic and gene rearrangement confirmation","volume":"148","author":"Bhat","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"key\n\t\t\t\t20170508182748_NOR203C42","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1177\/1545109708325467","article-title":"Hyper interleukin-10 in an HIV-positive child with t-cell lymphoma and candidal sepsis","volume":"7","author":"Lighter","year":"2008","journal-title":"J Int Assoc Physicians AIDS Care (Chic Ill)"},{"key":"key\n\t\t\t\t20170508182748_NOR203C43","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00005-010-0066-1","article-title":"Plasma TNF-alpha and IL-10 level-based prognostic model predicts outcome of patients with diffuse large B-Cell lymphoma in different risk groups defined by the International Prognostic Index","volume":"58","author":"Lech-Maranda","year":"2010","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"key\n\t\t\t\t20170508182748_NOR203C44","first-page":"485","article-title":"The effects of IL-2, IL-6 and IL-10 levels on prognosis in patients with aggressive Non-Hodgkin's Lymphoma (NHL)","volume":"23","author":"Ozdemir","year":"2004","journal-title":"J Exp Clin Cancer Res"},{"key":"key\n\t\t\t\t20170508182748_NOR203C45","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1182\/blood-2005-03-1024","article-title":"A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases","volume":"107","author":"Camilleri-Bro\u00ebt","year":"2006","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170508182748_NOR203C46","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1440-1789.2009.01074.x","article-title":"Primary central nervous system lymphoma: Immunohistochemical profile and prognostic significance","volume":"30","author":"Raoux","year":"2010","journal-title":"Neuropathology"},{"issue":"3","key":"key\n\t\t\t\t20170508182748_NOR203C47","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.4049\/jimmunol.155.3.1079","article-title":"IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes","volume":"155","author":"Finbloom","year":"1995","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20170508182748_NOR203C48","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1158\/1078-0432.CCR-08-1588","article-title":"Interaction between BCL2 and interleukin-10 gene polymorphisms alter outcomes of diffuse large B-cell lymphoma following rituximab plus CHOP chemotherapy","volume":"15","author":"Park","year":"2009","journal-title":"Clin Cancer Res"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/14\/3\/368\/16663689\/nor203.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T19:14:16Z","timestamp":1686510856000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-lookup\/doi\/10.1093\/neuonc\/nor203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,12]]},"references-count":48,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2011,12,12]]},"published-print":{"date-parts":[[2012,3]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/nor203","relation":{},"ISSN":["1523-5866","1522-8517"],"issn-type":[{"value":"1523-5866","type":"electronic"},{"value":"1522-8517","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12,12]]}}}